A federal judge on Monday threw out a $96 million jury verdict against genetic testing company CareDX that rival Natera had ...

Q4 2024 Earnings Call Transcript February 28, 2025 Operator: Welcome everyone to Natera’s 2024 Fourth Quarter Financial ...

Genetic testing company Natera (NASDAQ:NTRA). reported Q4 CY2024 results beating Wall Street’s revenue expectations, with ...

Natera Inc (NTRA) reports a 53% revenue surge and outlines strategic initiatives amidst competitive pressures and ...

Natera Inc. (($NTRA)) has held its Q4 earnings call. Read on for the main highlights of the call. Natera Inc. Reports Strong Financial Performance ...

BTIG analyst Mark Massaro raised the firm’s price target on Natera (NTRA) to $190 from $185 and keeps a Buy rating on the shares. The company ...

In a report released today, David Westenberg from Piper Sandler maintained a Buy rating on Natera (NTRA – Research Report), with a price target ...

Q4 2024 Earnings Conference Call February 27, 2025 4:30 PM ETCompany ParticipantsMike Brophy - Chief Financial ...

Welcome, everyone, to Natera's 2024 fourth-quarter financial results conference call. (Operator Instructions) As a reminder, this conference call is being recorded, today, February 27, 2025. I would, ...

Medical diagnostics company Guardant Health has sued rival Natera in California federal court for allegedly stealing trade ...

Natera (NASDAQ:NTRA – Get Free Report) is anticipated to issue its quarterly earnings data after the market closes on Thursday, February 27th. Analysts expect the company to announce earnings of ...

Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA and genetic testing, today announced that its Signatera test has met coverage requirements from the Centers for Medicare & Medicaid ...